Advances in multichannel SPR instruments are moving kinetic analysis from secondary validation to primary screening, generating richer data for AI-driven discovery and lead selection.
Emerging data shows alpha synuclein may be present in the majority of neurodegenerative disease cases, reshaping how clinicians understand dementia and Parkinson’s.
The rise of iPSC-derived immune cells and CRISPR-based engineering is reshaping functional genomics, but protein-level validation has struggled to keep pace.
Innovations in chromatographic system design are helping scientists improve analytical reliability and generate higher-quality data for challenging compounds.